Combination Chemotherapy in Treating Patients With Resected Colon Cancer
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug is a way to kill more tumor cells.
PURPOSE: Randomized phase III trial to determine the effectiveness of uracil, tegafur,and
leucovorin compared with fluorouracil plus leucovorin in patients with resected stage II or
stage III colon cancer.